1.A long-term prognosis predictive model of ejection fraction preserved HF elderly patients using two-dimensional speckle tracking technology
Zhiyong LI ; Huaping FENG ; Shengfeng LAN ; Xing LI
Chinese Journal of Geriatric Heart Brain and Vessel Diseases 2024;26(10):1138-1142
Objective To construct a prediction model for the long-term prognosis of elderly pa-tients heart failure with preserved ejection fraction(HFpEF)based on two-dimensional speckle tracking technology.Methods A total of 312 elderly HFpEF patients admitted in our hospital from January 2017 to December 2018 were prospectively enrolled,and then randomly divided into a training set(218 cases)and a validation set(94 cases)in a ratio of 7∶3.After 5 years of follow-up,they were divided into a death group(n=128)and a survival group(n=184)according to having experienced cardiovascular death events or not.The main clinical characteristics were com-pared between the two groups,and the risk factors for cardiovascular death events were analyzed.A clinical prediction model was constructed based on the relevant risk factors with R4.0.3 statisti-cal software.Results The age,age ≥80 years,atrial fibrillation,chronic obstructive pulmonary disease(COPD),and early strain rate of global systole(GSRs)in the death group were signifi-cantly higher than those in the survival group,with statistical significances[(76.68±8.73)years vs(70.98±7.74)years,P<0.01;34.4%vs 20.7%,P<0.01;25.0%vs 11.4%,P<0.01;26.6%vs 9.2%,P<0.01;(-0.84±0.24)/s vs(-1.24±0.31)/s,P<0.01].Multivariate logistic regression analysis showed that age ≥80 years,atrial fibrillation,COPD and GSRs>-1.035 1/s were inde-pendent risk factors for cardiovascular death events(RR=2.196,95%CI:1.217-3.962,P=0.009;RR=2.242,95%CI:1.136-4.424,P=0.020;RR=3.631,95%CI:1.787-7.377,P=0.000;RR=6.199,95%CI:3.624-10.602,P=0.000).The AUC value of the training set was 0.822(95%CI:0.765-0.879),and that of the validation set was 0.790(95%CI:0.698-0.882).Conclusion Our constructed nomogram prediction model has high predictive value and reliability in predicting cardiovascular death events.
2.Phase I metabolism of four amide synthetic cannabinoids in human liver microsomes
Shengfeng LIU ; Lan ZHANG ; Shucheng LIU ; Chenzhi HOU ; Peng XU ; Bin DI
Journal of China Pharmaceutical University 2022;53(5):577-590
This study was performed to determine the metabolic profile of four amide synthetic cannabinoids that recently abused, i.e., ADB-4en-PINACA, 4CN-CUMYL-BUTINACA, 5F-EMB-PICA and 4F-MDMB-BUTICA, in human liver microsomes (HLMs). The four amide synthetic cannabinoids were added to the microsomal incubation model, being incubated for 10 min, 60 min or 3 h to simulate human hepatic metabolism.Liquid chromatography quadrupole time-of-flight mass spectrometry (LC-QTOF-MS) analytical instrument was employed to determine and speculate the structure of phase I metabolites and their possible metabolic pathways.The results showed that there were 27 phase I metabolic pathways for the four amide synthetic cannabinoids, including hydroxylation, carboxylation, N-dealkylation and ester hydrolysis, with the main phase I metabolic pathways of ester hydrolysis, dihydrodiol (pentenyl tail), oxidative defluorination to carboxylic acid, monohydroxylation (alkyl side chain or indole/indazole ring) and N-dealkylation.The results of this study may provide potential detection markers for forensic identification and sewage abuse assessment of the four amide synthetic cannabinoids.

Result Analysis
Print
Save
E-mail